Free Trial

Molecular Partners (MOLN) SEC Filings & 10K Form

Molecular Partners logo
$5.44 +0.36 (+7.09%)
(As of 05:26 PM ET)

Recent Molecular Partners SEC Filings

DateFilerForm TypeView
10/31/2024
3:00 PM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
3:32 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Partners (Subject)
Form SC 13D/A
10/28/2024
3:05 PM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
8:20 AM
Molecular Partners (Filer)
Form 424B5
10/22/2024
8:02 AM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2024
3:03 PM
Molecular Partners (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/14/2024
9:44 AM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/11/2024
9:16 AM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/17/2024
5:25 AM
Molecular Partners (Filer)
Form 6-K/A
03/26/2024
8:34 AM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
11:33 AM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MOLN) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners